ABUS vs PLD · P/E 5.4, rev $6.2M vs P/E 27, rev $8.79B
Arbutus Biopharma Corp (ABUS) versus Prologis Inc (PLD) — a side-by-side from cached financials, not a winner call.
Arbutus Biopharma Corp (ABUS) is a biotechnology company listed on NASDAQ.
Prologis Inc (PLD) is a reit - industrial company listed on US.
Latest reported ABUS revenue for 2024-12-31 was $6.2M. Net income was -$69.9M. Revenue was down 66.0% from 2023-12-31 to 2024-12-31. ABUS currently screens at market cap $883.0M and trailing P/E 5.4.
Latest reported PLD revenue for 2025-12-31 was $8.79B. Net income was $3.33B. Revenue was up 7.2% from 2024-12-31 to 2025-12-31. PLD currently screens at market cap $100.23B and trailing P/E 26.9.
ABUS currently screens at market cap $883.0M and trailing P/E 5.4. PLD currently screens at market cap $100.23B and trailing P/E 26.9.
Not investment advice. Open the ABUS and PLD stock pages for the full models.
Not investment advice.